Elamipretide Pronunciation: How to Say It Correctly

The most common way to say elamipretide is “eh-LAM-ih-pruh-tide” — five syllables, stress on the second syllable, and a final syllable that rhymes with “tide.” You will also hear “el-uh-MIP-ruh-tide,” which is equally acceptable in clinical and research settings. There is no single official pronunciation, but those two versions cover nearly every conversation about the drug.

Elamipretide Pronunciation, Syllable by Syllable

The name breaks cleanly into five spoken parts. Read the table left to right, then say the whole word without pausing between rows.

Syllable	Sounds like	What to do
eh	“eh” in bed	Short and light; do not stretch it into “ee.”
LAM	“lam” in lamb, without the b	This is the stressed syllable — say it slightly louder and longer.
ih	“ih” in bit	Quick and soft, almost swallowed.
pruh	“pruh” in pruh-nounce	A neutral schwa; keep it short.
tide	“tide” in ocean tide	Rhymes with wide and side.

Put together, the rhythm is da-DA-da-da-da: eh-LAM-ih-pruh-tide. Saying it out loud three or four times in a row is usually enough to lock it in.

Stress, Speed, and the Mistakes to Avoid

Almost every mispronunciation of elamipretide comes from putting the emphasis in the wrong place or flattening the final syllable.

• Do stress the “LAM” syllable: eh-LAM-ih-pruh-tide.
• Don’t say “el-uh-mip-ruh-TEED.” The last syllable rhymes with “tide,” not “need.”
• Don’t say “ee-LAM-ih-preh-tide.” The first syllable is a short “eh,” not “ee.”
• Don’t drop the middle. The “ih-pruh” section is short, but it is still there.

The second accepted version, “el-uh-MIP-ruh-tide,” shifts the stress to the third syllable. That difference is minor, and researchers, pharmacists, and patient advocates use both forms.

Why So Many Peptide Names End in “-tide”

Elamipretide belongs to a large family of peptide and protein drugs whose names end in the suffix “-tide.” In drug naming, that suffix signals a peptide or protein, and it is almost always pronounced to rhyme with “tide.”

That one rule solves half the pronunciation problem for this entire class of medications. If you can say “tide,” you can say the ending of elamipretide, semaglutide, tirzepatide, and dozens of other names.

The harder part is usually the beginning of the word, which is why so many people search for a specific peptide name rather than the suffix itself.

How Elamipretide Compares to Other Peptide Names

Many readers look up several peptide names in the same sitting. The table below shows how elamipretide fits alongside a few others that come up in the same searches.

Name	Common pronunciation	Stressed syllable
Elamipretide	eh-LAM-ih-pruh-tide	2nd
Cagrilintide	kag-rih-LIN-tide	3rd
Semaglutide	sem-uh-GLOO-tide	3rd
Tirzepatide	teer-ZEP-uh-tide	2nd
Ipamorelin	ee-puh-MOR-eh-lin	3rd
Tesamorelin	tes-uh-mor-EH-lin	4th

Notice how much the stress point moves around from drug to drug. A cagrilintide pronunciation guide puts the emphasis on “LIN,” while an ipamorelin pronunciation guide puts it on “MOR,” and a tesamorelin pronunciation guide usually lands on the “EH” near the end. Elamipretide is one of the few in this group that stresses an early syllable, which is a big reason it sounds unfamiliar at first.

What Elamipretide Is and Why People Look It Up

Elamipretide is an investigational tetrapeptide designed to target mitochondria, the energy-producing structures inside cells. It has also been studied under the names SS-31, MTP-131, and Bendavia, which is one reason spelling and pronunciation questions keep coming up.

Questions about elamipretide uses usually follow the pronunciation question closely. The drug has been researched for Barth syndrome, primary mitochondrial myopathy, and dry age-related macular degeneration, among other conditions.

Anyone reading up on an elamipretide clinical trial will see the name written far more often than they hear it spoken. That gap between reading a term and saying it out loud is exactly why pronunciation searches exist for so many peptides.

Elamipretide is not FDA-approved for human use in the United States as of this writing. It remains an investigational therapy, and anyone with questions about it should talk with a healthcare professional instead of relying on online summaries.

Quick Tips for Saying It Out Loud

Before an Appointment or Presentation

• Write it phonetically the way it sounds to you: eh-LAM-ih-pruh-tide.
• Say it five times slowly, then five times at normal speed.
• Record yourself once and compare it to a medical dictionary audio clip.

When You Are Still Not Sure

Spell it instead. Saying “e-l-a-m-i-p-r-e-t-i-d-e” is never wrong, and most clinicians will confirm the pronunciation without a second thought. In writing, the drug is almost always referred to by its full generic name rather than an abbreviation.

Pronunciation is a small detail, but getting it right makes conversations with pharmacists, researchers, and physicians noticeably smoother.

COMMON QUESTIONS

Frequently Asked Questions

How do you pronounce elamipretide?

The most common pronunciation is “eh-LAM-ih-pruh-tide,” with the stress on the second syllable and a final syllable that rhymes with “tide.” A second accepted version is “el-uh-MIP-ruh-tide,” which stresses the third syllable. There is no single official pronunciation, and both forms are widely understood.

What is elamipretide used for?

Elamipretide is an investigational mitochondria-targeted peptide that has been studied for Barth syndrome, primary mitochondrial myopathy, and dry age-related macular degeneration. It has also appeared in research under the names SS-31, MTP-131, and Bendavia. It is not FDA-approved for human use in the United States as of this writing.

Is elamipretide FDA-approved?

No. Elamipretide is not FDA-approved for human use in the United States as of this writing and remains an investigational therapy. That means it is not available by prescription and should not be purchased from unregulated sources. Anyone with questions about access or safety should speak with a healthcare professional.